SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0000812796-09-000038
Filing Date
2009-04-17
Accepted
2009-04-16 19:02:24
Documents
3
Effectiveness Date
2009-04-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A PROXY - REVISION defr14aproxy.htm DEFR14A 312663
2 DOR LOGO doritslogo.jpg GRAPHIC 7451
3 5 YEAR MARKET GRAPH graphmarket5.jpg GRAPHIC 77454
  Complete submission text file 0000812796-09-000038.txt   431554
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-452-0001
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 000-16929 | Film No.: 09754736
SIC: 2834 Pharmaceutical Preparations